Glucose variability is a marker for COVID-19 severity and mortality

Glucose variability is a marker for COVID-19 severity and mortality

ABSTRACT Objective: We aimed to investigate the association between glucose coefficient of variation (CV) and mortality and disease severity in hospitalized patients with coronavirus disease-19 (COVID-19). Subjects and methods: Retrospective cohort study in a tertiary center of patients with COVID...

Full description

Bibliographic Details
Main Authors:	Ran Abuhasira, Alon Grossman
Format:	Article
Language:	English
Published:	Brazilian Society of Endocrinology and Metabolism 2022-10-01
Series:	Archives of Endocrinology and Metabolism
Subjects:	Glucose variability COVID-19 hyperglycemia hospital management
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000600856&tlng=en

Similar Items

Glucose Variability: How Does It Work?
by: Vadim V. Klimontov, et al.
Published: (2021-07-01)

Reference values of 24-hour, day-time and nocturnal glucose variability parameters in subjects with normal glucose tolerance
by: Ju. F. Semenova, et al.
Published: (2022-05-01)

The Relationship Between the Admission Blood Glucose Level and 90-Day Mortality in Non-Diabetic Patients with Coronavirus Disease-2019
by: Emre Sedar Saygılı, et al.
Published: (2022-02-01)

Hyperglycemia and glucose variability are associated with worse survival in mechanically ventilated COVID-19 patients: the prospective Maastricht Intensive Care Covid Cohort
by: Thijs T.W. van Herpt, et al.
Published: (2023-12-01)

Incidence and Risk Factors for Glucose Disturbances in Premature Infants
by: Ivona Butorac Ahel, et al.
Published: (2022-09-01)

Bioinformatic Reconstruction and Analysis of Gene Networks Related to Glucose Variability in Diabetes and Its Complications
by: Olga V. Saik, et al.
Published: (2020-11-01)

Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019
by: Jiaoyue Zhang, et al.
Published: (2020-07-01)

Unmanaged Diabetes and Elevated Blood Glucose Are Poor Prognostic Factors in the Severity and Recovery Time in Predominantly Hispanic Hospitalized COVID-19 Patients
by: Sudip Bajpeyi, et al.
Published: (2022-07-01)

Observational study on SavenG protocol of glucose control in intensive care unit
by: Sanjith Saseedharan, et al.
Published: (2022-01-01)

Hyperglycemia and elevated C‐reactive protein are independent predictors of hospital mortality in hospitalized COVID‐19 patients in South‐Kivu, eastern Democratic Republic of the Congo: A cross‐sectional study
by: Christian Tshongo, et al.
Published: (2024-01-01)

Fasting Glucose for the Diagnosis of Gestational Diabetes Mellitus (GDM) during the COVID-19 Pandemic
by: Nieves Luisa González González, et al.
Published: (2022-08-01)

Effect of Repeated Bolus and Continuous Glucose Infusion on DNA Damage and Oxidative Stress Biomarkers in Healthy Male Volunteers
by: Laura Bragagna, et al.
Published: (2023-09-01)

Biological characteristics and mortality in patients with diabetes and COVID-19
by: Nousseiba ABED, et al.
Published: (2022-09-01)

COVID-19 and Diabetes
by: Virginia Bellido, et al.
Published: (2021-11-01)

Newly-Diagnosed Diabetes and Sustained Hyperglycemia are Associated with Poorer Outcomes in COVID-19 Inpatients Without Pre-Existing Diabetes
by: Lin L, et al.
Published: (2021-11-01)

Elevated D-dimer and Adverse In-hospital Outcomes in COVID-19 Patients and Synergism with Hyperglycemia
by: Li H, et al.
Published: (2022-07-01)

The Effect of Atypical Anti-psychotic Agents on Obesity and Glucose Metabolism
by: Sang Ah Lee, et al.
Published: (2021-12-01)

Stress Hyperglycemia Ratio as a Prognostic Marker in Diabetic Patients Hospitalized with COVID-19
by: Mohamed Aon, et al.
Published: (2022-09-01)

Impact of in-hospital versus ambulatory glucose variability on coronary plaque vulnerability in patients with coronary artery disease
by: Kazuya Tateishi, et al.
Published: (2022-10-01)

Saliva as a diagnostic tool for glucose estimation in diabetic patients
by: Deepali Pandey, et al.
Published: (2023-01-01)

Association between Hyperglycemia at Hospital Presentation and Hospital Outcomes in COVID-19 Patients with and without Type 2 Diabetes: A Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients
by: Nipith Charoenngam, et al.
Published: (2021-06-01)

Evaluation of the relationship between COVID-19 and hyperglycemia
by: Seval Muzeyyen Ecin, et al.
Published: (2022-03-01)

Impact of newly diagnosed diabetes on coronavirus disease 2019 severity and hyperglycemia
by: Masaki Uchihara, et al.
Published: (2022-06-01)

Characteristics and Clinical Outcomes of COVID-19 Patients with Hyperglycemia: Retrospective Cohort Study from a COVID-19 Referral Hospital, Bandung, Indonesia
by: Hikmat Permana, et al.
Published: (2023-12-01)

Effects of Momordica cochinchinensis spreng, fruit on the proliferation and angiogenesis biomarkers of human retinal pigment epithelial cells under high glucose conditions
by: Mahdi, Ali AbdulQader Mahdi
Published: (2019)

Effect of birth asphyxia on neonatal blood glucose during the early postnatal life: A multi-center study in Hubei Province, China
by: Chun-Hua Liu, et al.
Published: (2023-09-01)

Dexamethasone use and insulin requirements in coronovirus-19 (COVID-19) infection stratified by Hemoglobin A1c
by: Caitlyn Gordon, et al.
Published: (2023-04-01)

Comparison between 100-g glucose tolerance test and two other screening tests for gestational diabetes: combined fasting glucose with risk factors and 50-g glucose tolerance test
by: Wilson Ayach, et al.

Flash glucose monitoring in gestational diabetes mellitus: possibilities for assessing glycemic variability
by: F. O. Ushanova, et al.
Published: (2021-09-01)

Continuous glucose monitoring for detection of glycemic variability, hypoglycemia, and hyperglycemia in women with eating disorders
by: Nao Uotani, et al.
Published: (2022-10-01)

Glycemia, Beta-Cell Function and Sensitivity to Insulin in Mildly to Critically Ill Covid-19 Patients
by: Ioannis Ilias, et al.
Published: (2021-01-01)

Frequency of Stress Hyperglycemia and Its Effect on Disease Outcome in COVID-19 Patients Referred to the Imam Khomeini Medical Education Center in Sari
by: Maryam Mosayyebi, et al.
Published: (2023-12-01)

Risk factors for severe disease and mortality in children with COVID-19
by: Laura Flores-Cisneros, et al.
Published: (2024-01-01)

Admission Blood Glucose and 2-Year Mortality After Acute Myocardial Infarction in Patients With Different Glucose Metabolism Status: A Prospective, Nationwide, and Multicenter Registry
by: Kongyong Cui, et al.
Published: (2022-06-01)

Relationship between Fasting and Postprandial Glucose Levels and the Gut Microbiota
by: Yui Mineshita, et al.
Published: (2022-07-01)

COVID-19 and the Risk of Diabetes: A Systematic Review Article
by: Noor Mohamed-Jawad, et al.
Published: (2023-07-01)

Knowledge and Practice of Glucose Self-Monitoring Devices among Patients with Diabetes
by: Sami Mohamed, et al.
Published: (2023-06-01)

A Simple Photometer as a Helping Device in Measuring Blood Glucose
by: Aryo Tedjo, et al.
Published: (2014-09-01)

Stress hyperglycemia, Diabetes mellitus and COVID-19 infection: The impact on newly diagnosed type 1 diabetes
by: Ioanna Farakla, et al.
Published: (2022-08-01)

Glucose Metabolism in Burns—What Happens?
by: Silviu Constantin Badoiu, et al.
Published: (2021-05-01)